-
Target
Xendo Drug Development
-
Our Role
Advisor to seller
-
Seller and Location
Xendo Holding B.V., Netherlands
-
Activity
Provides services, consultancy and contract research to the life sciences sector
-
Acquiror / Investors and Location
QPS Holding, LLC, United States
-
Activity
Provides quality services in regulated and non-regulated bioanalysis, DMPK, protein biomarkers, pharmacogenomics and pharmacogenetics markers, and Phase 1 studies
-
Description of Transaction
Advised Xendo Holding B.V. on the divestment of its subsidiary Xendo Drug Development B.V. to QPS Holding, LLC. Xendo Drug Development is a full-service Contract Research Organization (CRO) focused on improving drug quality and safety.
